1.8B

Money

Genmab Buys ProfoundBio for $1.8B to Boost Oncology Portfolio

KEY TAKEAWAYS Danish drugmaker Genmab said Wednesday that it is buying privately held U.S. biotech firm ProfoundBio for $1.8 billion…

Read More »
Back to top button